Apollo Hospitals AICKD
Apollo Hospitals Enterprise Ltd · Operations & Productivity
Certification per Microsoft Marketplace.
Evidence tier Source Confirmed · 8 captures on record
What the publisher says
As described on Microsoft Marketplace.
- A Deep Learning Model, developed using Indian datasets, demonstrates
superior accuracy compared to conventional risk scores.
Show the rest of the publisher’s description (19 more lines)
- Feedback Loop from the prospective use in patients
- Comprehensive & Holistic Risk Assessment
- Validated at different National Institutions
- Integrated Clinical Decision Support Tool (What Next to Do)
- QMS: ISO 13485:2016 and MDSAP certified
Interpretation
& Adoption Message
- AI Algorithm + Clinicians: This Disease progression Assessment
tool has been built as an adjunct tool for physicians to identify the
progression of CKD patients into different stages and End-stage renal failure.
- Risk Identification: This
Disease Progression Assessment Tool is not intended for diagnosing chronic
kidney disease (CKD). Its use is restricted to pediatric populations,
individuals not diagnosed with CKD, those in CKD Stage 5, or patients
undergoing treatments such as dialysis, transplants, or medications
specifically targeting CKD progression.
- Where to use: This Disease progression assessment tool is designed for
use at Outpatient Nephrology clinics, Inpatient Nephrology units,
standalone Nephrology units, and Dialysis centers.
Preview
4 images
Agent build and provenance
Sign in to see the provenance.
The evidence, the layer-by-layer tracing, the risk basis, and the cross-marketplace links are open to signed-in accounts.
Sign inCompliance
- FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27
Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.
Vendor
External enrichment · as of 2026-08-07
Plans and pricing as listed
1 listed- API Call Details/Unit Price: $3.65 per api call
Sources
Publisher resources
3 linksEvidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.